Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ITCI - Intra-Cellular Therapies, Inc.
104 K
LAST VALUE
51.19%
2 YEAR CAGR
16.61%
5 YEAR CAGR
1972.74%
10 YEAR CAGR